Abstract
Aim: This work aimed to elucidate the mechanisms of Se@Tri-PTs in alleviating podocyte injury via network pharmacology and in vitro cellular assay.
Background: Selenized tripterine phytosomes (Se@Tri-PTs) have been confirmed to undertake synergistic and sensitized effects on inflammation, which may be curatively promising for diabetic nephropathy (DN). However, the mechanisms of Se@Tri-PTs in alleviating podocyte injury, a major contributor to DN, still remain unclear.
Objective: The objective of the study was to find out the underlying mechanisms of Se@Tri-PTs in alleviating podocyte injury in diabetic nephropathy.
Methods: The key components and targets of Tripterygium wilfordii (TW) significant for DN as well as the signaling pathways involved have been identified. A high glucose-induced podocyte injury model was established and verified by western blot. The protective concentration of Se@Tri-PTs was screened by CCK-8 assay. Podocytes cultured with high glucose were treated with Se@Tri-PTs under protective levels. The expression of key protective proteins, nephrin and desmin, in podocytes, was assayed by western blot. Further, autophagy- related proteins and factors, like NLRP3, Beclin-1, LC3II/LC3, P62, and SIRT1, were analyzed, which was followed by apoptosis detection.
Results: Network pharmacology revealed that several monomeric components of TW, especially Tri, act on DN through multiple targets and pathways, including the NLRP3-mediated inflammatory pathway. Se@Tri-PTs improved the viability of podocytes and alleviated their injury induced by high glucose at 5 μg/L or above. High-glucose induction promoted the expression of NLRP3 in podocytes, while a low concentration of Se@Tri-PTs suppressed the expression. A long-term exposure of high glucose significantly inhibited the autophagic activity of podocytes, as manifested by decreased Beclin-1 level, lower ratio of LC3 II/LC3 I, and up- regulation of P62. This abnormality was efficiently reversed by Se@Tri-PTs. Importantly, the expression of SIRT1 was up-regulated and podocyte apoptosis was reduced.
Conclusion: Se@Tri-PTs can alleviate podocyte injury associated with DN by modulating NLRP3 expression through the pathway of SIRT1-mediated autophagy.
Keywords: Tripterine, phytosomes, network pharmacology, diabetic nephropathy, podocyte injury, autophagy.
[http://dx.doi.org/10.1016/j.prostaglandins.2022.106621] [PMID: 35131551]
[http://dx.doi.org/10.1016/j.kisu.2017.07.009] [PMID: 30675428]
[http://dx.doi.org/10.18433/jpps32911] [PMID: 35760072]
[http://dx.doi.org/10.3390/ijms222312766] [PMID: 34884572]
[http://dx.doi.org/10.3390/ijms22115603] [PMID: 34070553]
[http://dx.doi.org/10.3390/ijms21186686] [PMID: 32932720]
[http://dx.doi.org/10.1016/j.ejphar.2020.173387] [PMID: 32710953]
[http://dx.doi.org/10.1016/j.fitote.2019.104190] [PMID: 31163199]
[http://dx.doi.org/10.1016/j.intimp.2022.108871] [PMID: 35605435]
[http://dx.doi.org/10.1002/jps.23967] [PMID: 24700417]
[http://dx.doi.org/10.1016/j.cclet.2020.11.048]
[http://dx.doi.org/10.1016/j.cclet.2022.03.077]
[http://dx.doi.org/10.2147/IJN.S181343] [PMID: 30532534]
[http://dx.doi.org/10.1007/978-1-4939-9841-8_1] [PMID: 31701441]
[http://dx.doi.org/10.1016/j.ebiom.2018.09.031] [PMID: 30268831]
[http://dx.doi.org/10.1002/ptr.6314] [PMID: 30768745]
[http://dx.doi.org/10.1016/j.ijpharm.2020.119104] [PMID: 32018017]
[http://dx.doi.org/10.1016/j.cclet.2020.03.066]
[http://dx.doi.org/10.1016/j.xkme.2020.10.005] [PMID: 33604542]
[http://dx.doi.org/10.1146/annurev-med-050311-163340] [PMID: 23190150]
[http://dx.doi.org/10.1016/j.cclet.2022.04.080]
[http://dx.doi.org/10.1016/j.ajpath.2021.11.004] [PMID: 34861215]
[http://dx.doi.org/10.2119/molmed.2017.00077] [PMID: 28741645]
[http://dx.doi.org/10.1016/j.autrev.2021.102976] [PMID: 34757091]
[http://dx.doi.org/10.4251/wjgo.v14.i2.375] [PMID: 35317317]
[http://dx.doi.org/10.1016/j.gene.2021.145532] [PMID: 33631244]
[http://dx.doi.org/10.1016/j.biocel.2021.106153] [PMID: 34974186]
[http://dx.doi.org/10.1016/j.bbrc.2021.04.025] [PMID: 33932899]
[http://dx.doi.org/10.1186/s11658-016-0031-z] [PMID: 28536631]
[http://dx.doi.org/10.1016/j.ejphar.2021.174629] [PMID: 34780751]